Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

ALX ONCOLOGY HOLDINGS INC (ALXO)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-05-22Dec-31-21Dec-05-21Dec-31-20Dec-31-19Dec-31-18
   10-K8-K10-K8-K10-K10-K10-K
Revenues  0.098.40.060.21.24.82.1
            Revenue growth   63.5%-100.0% -75.4%132.0% 
Cost of goods sold  0.0127.4-88.383.60.00.00.0
Gross profit  0.0-29.088.3-23.41.24.82.1
            Gross margin   -29.5% -38.9%100.0%100.0%100.0%
Selling, general and administrative   [+]29.029.023.423.414.83.32.6
Research and development  98.4 60.2 29.016.311.3
Other operating expenses   69.483.636.81.14.41.9
EBITDA   [+]-127.1 -78.8 -43.5-18.8-13.3
            EBITDA margin   -129.5% -138.9%-3677.1%-391.0%-641.2%
Depreciation and amortization  0.3 0.1 0.20.40.4
EBIT   [+]-127.4-127.4-78.8-83.6-43.7-19.2-13.7
            EBIT margin   -129.5% -138.9%-3694.0%-400.0%-662.0%
Non-recurring items    4.7    
Interest income, net   [+]4.34.30.10.10.10.0 
Other income (expense), net   [+]-0.3-0.30.00.0-2.00.00.0
Pre-tax income  -123.4-123.4-83.5-83.5-45.5-19.2-13.7
Income taxes  0.10.10.00.00.20.00.0
            Tax rate    0.0%0.0%   
Net income  -123.5-123.5-83.5-83.5-50.9-23.3-17.4
            Net margin   -125.5% -138.7%-4309.8%-485.2%-841.9%
   
Basic EPS   [+]($3.03)($3.03)($2.07)($2.07)($2.76)($7.56)($6.33)
Diluted EPS   [+]($3.03)($3.03)($2.07)($2.07)($2.76)($7.56)($6.33)
   
Shares outstanding (basic)   [+]40.740.840.340.318.53.12.8
Shares outstanding (diluted)   [+]40.740.840.340.318.53.12.8
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy